Innovative AI software for the detection of pancreatic diseases: first-in-human application successful

Innovative AI software for the detection of pancreatic diseases: first-in-human application successful Diseases of the pancreas can have serious consequences for patients and are difficult...

Theraclion Announces First Patients Treated With SONOVEIN® in the US

THERACLION, an innovative company developing a scalable robotic platform for non-invasive echotherapy, has announced the treatment of varicose veins patients with SONOVEIN for the first...

Onward Medical enrols first patient in HemON Study

The study will enrol people with SCI suffering from orthostatic hypotension. Onward Medical, a Dutch medical technology company that focuses on creating therapies for people...

Hapbee Releases Results of Sleep Data Study Spanning Five Months of User Tracking

Biometric Data Shows Clear Correlation Between Hapbee Use and Improved Sleep Metrics As Measured by Oura Ring Surveyed Hapbee users shared their Oura Ring sleep...

Medtronic enrolls first patient in trial of Evolut TAVR system in patients with aortic stenosis

Medtronic (NYSE:MDT) announced that it enrolled the first patient in its Expand TAVR II pivotal trial. Expand TAVR II will evaluate the self-expanding, supra-annular Evolut transcatheter...

Study results show improved time in range with Diabeloop automated insulin delivery system

Diabeloop announced that study data support the use of its DBLG1 hybrid closed-loop automated insulin delivery system. Paris-based Diabeloop’s real-life German cohort data, presented at...

CathVision concludes patient enrolment in EP recording technology trial

ECGenius comprises a 12-lead ECG, four blood pressure channels and 128 intracardiac channels. CathVision has concluded patient enrolment in the clinical trial of its low-noise electrophysiology (EP)...

First patient in the world implanted with Abiomed Impella BTR heart pump

Abiomed announced the first patient in the world was successfully treated with its Impella Bridge-to-Recovery (BTR) as part of an early feasibility study. The first...

Masimo SedLine® Brain Function Monitoring Reduced the Use of Anesthetic Agents and Opioids in a Study on Patients Undergoing Cardiac Surgery

Masimo (NASDAQ: MASI) announced the findings of a retrospective study published in the Journal of Cardiothoracic and Vascular Anesthesia in which Dr. André Denault and colleagues at...

Latest articles